Our new pick is MHCC – Millennium Healthcare
Good Morning Readers And Welcome New Subscribers!
Did you happen to catch our report last night on MHCC?
If not, no worries, we have included it below but first lets take a look at a Press Release from this morning.
Just this morning, MHCC announced that through the continued expansion of its distribution network in 2014 and its outlook for 2015 and through its expanding pipeline of new, innovative, and non-invasive medical devices focused on preventative care and early detection, the Company is well positioned to become a leading distributor for not only primary care physicians but also for other growing healthcare segments, such as the growing number of primary care physicians moving into the urgent care industry.
According to research by A.T. Kearney in “Medical Devices: Equipped for the Future?”, the cash value generation potential in the medical device industry could potentially grow to a $34B by 2020.
Chris Amandola, Millennium’s President, stated, “Millennium is well positioned to become a leader in the medical device industry.
Management is also looking to deliver our products and services to new markets, such as the growing number of primary care physicians moving into the urgent care market, which is a market is currently estimated at $17 billion.
We believe Millennium has been built on a solid foundation and is positioned to move with future industry shifts, maintaining the company’s potential to continue to grow well into the future.”
MHCC has a last price just under .05c a share with a 52 week high of .74c
MHCC has been heating up lately and a steady increase of volume with the share price remaining pretty flat for the past few months. We believe this could be a sign of whats to come.
First things first, let us hit you with this little piece of information. MHCC had over 8M in revenues in 2014. No, I didn’t studder, 8.341M in revenues in 2014. In 2013 MHCC had 1.987M and in 2012 1.686M in revenues.
That’s over a 300% increase in revenue from 2013 to 2014 for this nickel priced company.
MHCC is a healthcare services and medical device distribution company.
Their web site can be seen here.
MHCC through its wholly owned operating subsidiaries, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting-edge medical devices focused primarily on preventive care through early detection. The Company also provides advanced billing and coding services, and practice development and management services.
MHCC products & services:
Even though the “BrushTest” is used in your mouth it has nothing to do with teeth. The OralCDx BrushTest is a virtually painless way for a dentist or physician to test common oral spots (subtle red or white spots) that may appear in your mouth from time to time. The special brush has tiny bristles that collect cells as the tool is applied and rotated on the oral spot. It can be used anywhere in the mouth.
Once the cells have been collected, the specimen is sent to CDx Diagnostics. It’s the only lab in the world that can process the sample. World class pathologists using sophisticated computer technology help doctors determine the cause of the common oral spot while making sure that the abnormality is not precancer or cancer. OralCDx can also help the clinician decide if a scalpel biopsy is necessary to investigate the area further
Skin cancer biopsy test
Designed to analyze the autonomic nervous system function, stress and peripheral blood circulation. It provides objective data to help assess disorder such as depression, anxiety, sleep disorder, poor concentration, mentel/physical stress degree, chronic fatigue and blood circulation.
On May 7 2015 MHCC issues a shareholder update.
Millennium Healthcare Inc. as an early stage emerging growth company in the medical device industry and is rapidly becoming a sales innovator in bringing exclusive medical device technology to previously underserved or overlooked distribution channels. Millennium is fast developing a network of ACO’s (Accountable Care Organizations) and PHO’s (Physician Hospital Organizations) that have embraced the Company’s product offerings.
We would like to take a moment to update you as well as recap our performance over the last year and provide some insights into our future developments.
Millennium has been diligently focused on growing its business in the medical device industry. Our management team has been completely immersed in developing new distribution channels for our products and services. The third quarter of 2014 was the first full quarter where the Company executed its strategy of providing exclusive diagnostic devices to primary care physician groups. The third and fourth quarter 2014 sales of our OralCDx® and VasoScan™ diagnostic devices exceeded anticipated results.
Management believes that the current share price does not reflect the overall value of the enterprise. The Company has seen a dramatic increase in the amount of shares traded in its common stock. This increase in activity represents an increase in investor interest and shareholder diversity. In 2013 our Company’ shares traded on average approximately 31,665 shares per day. In 2014 our Company’s shares have traded on average approximately 247,454 shares per day. During 2015 our shares have currently traded on average approximately 600,000 shares per day. We feel that the increased liquidity of the Company’s stock is of great value to our shareholders and to the long-term performance of our common shares.
For the year-end 2013 our sales were $1.9M. For the year-end 2014 our sales increased to $8.34M. This represents approximately a 319% increase in sales.
This already extraordinary growth did not take into account fourth quarter 2014 device POs/Sales totaling $9.65M.
The Company was unable to recognize these sales in its overall annual 2014 revenues due to insufficient inventory as a result of undercapitalization. The Company anticipates being able to recognize and fulfill these orders during 2015. We continue to concentrate and focus on product training, implementation and certification, while increasing our receivable collections and capital raises to support our growth in 2015.
MHCC is doing big things and investors have been responding. Here are a few reason why you need to take a good hard look at MHCC tonight.
- Last price under .05c
- Return to 52 week high represents a 1400% gain!
- Revenues up 319% year over year
- Huge increase in average trading volume
- The US remains the largest medical device market in the world with a market size of around $110 B, and it is expected to reach $133 B by 2016.
Make Sure To Read Our Full Disclaimer:
The disclaimer is to be read and fully understood.
Movingpennies.com reports, alerts, and picks are advertisements and are for general information purposes only. We are engaged in the business of marketing and advertising companies for cash compensation unless otherwise stated. The paying party may own shares and may liquidate them during the promotional period.
We have been compensated three thousand five hundred dollars cash by a third party OTP Group LLC for marketing awareness on MHCC For 5/14/2015 and 5/15/2015
We encourage all to read the SEC’s Investor Alert before reading our Newsletter.
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.
This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Owners of this newsletter may buy and sell shares at the open market at any time during this email program. Because of this conflict, individuals are strongly encouraged to not using this newsletter as the basis for any investment decision. We are not responsible for any losses you may incur while using this newsletter and its services. If you do not agree with this statement then please leave this service immediately.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision.
Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Our website and newsletter are for entertainment purposes only. This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Gains mentioned in our newsletter and on our website may be based on End of Day or intraday data.
Through use of this email and/or website advertisement viewing or using you agree to hold Movingpennies.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Movingpennies.com sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by Movingpennies.com or an offer or solicitation to buy or sell any security.
Movingpennies.com does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Movingpennies.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is collected from public sources only such as the profiled company’s website, news releases, and corporate filings, but has not been verified in any way to ensure the publicly available information is correct. Movingpennies.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Movingpennies.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Movingpennies.com is compliant with the Can Spam Act of 2003. Movingpennies.com does not offer such advice or analysis, and Movingpennies.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.
In preparing this publication, Movingpennies.com has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. Movingpennies.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Movingpennies.com is not responsible for any claims made by the companies advertised herein, nor is Movingpennies.com responsible for any other promotional firm, its program or its structure.